Results 11 to 20 of about 16,563 (220)

Macular Cystoid Edema Induced by Nab-Paclitaxel

open access: yesActa Médica Portuguesa, 2022
A 61-year old male was referred to the Ophthalmology department because of decreased bilateral visual acuity. The patient had metastatic pancreatic adenocarcinoma and was being treated with gemcitabine+nab-paclitaxel. On examination, the patient presented best corrected visual acuities of 4/20 and 2/20 in the right and left eye, respectively.
Sara Alves Pereira   +3 more
openaire   +4 more sources

A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer

open access: yesBMC Cancer, 2021
Background Although various clinical trials and real-life studies have tried to explore the value of nab-paclitaxel mono-chemotherapy for metastatic breast cancer (MBC), the safety and efficacy of nab-paclitaxel remain unclear which need to be ...
Haili Lu   +8 more
doaj   +1 more source

Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin–Bound Paclitaxel in Rats

open access: yesJournal of Pharmacological Sciences, 2011
.: Nanoparticle albumin–bound paclitaxel (nab-paclitaxel) is delivered to tumors and increases antitumor activity compared with solvent-based paclitaxel.
Yuji Yamashita   +5 more
doaj   +1 more source

A Case of Stress Cardiomyopathy With Nab-Paclitaxel Infusion

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2023
Stress cardiomyopathy is a transient left ventricular dysfunction caused by physiologic or pathologic stressors. Anaphylaxis is a hypersensitivity disorder that can lead to a rapid life-threatening respiratory collapse. It happens due to exposure to allergens including medications.
Harjinder Singh   +3 more
openaire   +3 more sources

Efficacy and safety of nanoparticle albumin-bound paclitaxel in non-small cell lung cancer: a systematic review and meta-analysis

open access: yesArtificial Cells, Nanomedicine, and Biotechnology, 2019
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) offer more efficient paclitaxel delivery into tumor cells with fewer side effects than conventional chemotherapies.
Hong Tan, Jing Hu, Shan Liu
doaj   +1 more source

A case of hemorrhagic cystitis caused by nab-paclitaxel [PDF]

open access: yesInternational Cancer Conference Journal, 2016
Nab-paclitaxel (nab-PTX) is a nanoparticle albumin-bound paclitaxel and, as such, is free of solvents like ethanol and polyoxyethylene castor oil. The absence of solvents from this formulation has several practical advantages: it has a shorter infusion time, it negates the need for premedications for hypersensitivity reactions, and it can be ...
Emika, Ichioka   +9 more
openaire   +2 more sources

Efficacy and Safety of Albumin-Bound Paclitaxel Compared to Docetaxel as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer

open access: yesFrontiers in Oncology, 2022
BackgroundNanoparticle albumin-bound paclitaxel (nab-paclitaxel) as neoadjuvant chemotherapy (NAC) for breast cancer remains controversial. We conducted a retrospective study to compare the efficacy and safety of nab-paclitaxel with those of docetaxel as
Zhi-Dong Lv   +7 more
doaj   +1 more source

A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo.

open access: yesPLoS ONE, 2021
We developed a novel preparative method for nanoparticle albumin-bound (nab) paclitaxel with high drug loading, which was based on improved paclitaxel solubility in polyethylene glycol (PEG) and self-assembly of paclitaxel in PEG with albumin powders ...
Yue Gao   +15 more
doaj   +1 more source

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer. [PDF]

open access: yesPLoS ONE, 2013
Gastric cancer is the second common cause of cancer related death worldwide and lacks highly effective treatment for advanced disease. Nab-paclitaxel is a novel microtubule-inhibitory cytotoxic agent that has not been tested in gastric cancer as of yet ...
Changhua Zhang   +4 more
doaj   +1 more source

Neoadjuvant nab-paclitaxel in the treatment of breast cancer [PDF]

open access: yesBreast Cancer Research and Treatment, 2016
Neoadjuvant chemotherapy has the advantage of converting unresectable breast tumors to resectable tumors and allowing more conservative surgery in some mastectomy candidates. Chemotherapy agents, including taxanes, which are recommended in the adjuvant setting, are also considered in the neoadjuvant setting. Here, we review studies of nab-paclitaxel as
Ueno, Naoto T., Mamounas, Eleftherios P.
openaire   +2 more sources

Home - About - Disclaimer - Privacy